Literature DB >> 29365276

Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension.

Scott A Barman1, Feng Chen1,2, Xueyi Li1, Stephen Haigh1, David W Stepp1, Dmitry Kondrikov1, Keyvan Mahboubi1, Zsuzsanna Bordan1, Peter Traber3, Yunchao Su1, David J R Fulton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29365276      PMCID： PMC6005555          DOI： 10.1164/rccm.201711-2308LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Galectin-3: the bridge over troubled waters.

Authors:  Melanie Königshoff; Mauricio Rojas
Journal:  Am J Respir Crit Care Med       Date:  2012-03-01       Impact factor: 21.405

2.  Usefulness of a mouse model of reversible pulmonary arterial hypertension: be cautious, choose carefully.

Authors:  José Gomez-Arroyo; Norbert F Voelkel; Harm J Bogaard; Laima Taraseviciene-Stewart
Journal:  Am J Respir Crit Care Med       Date:  2012-06-15       Impact factor: 21.405

3.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Authors:  L Taraseviciene-Stewart; Y Kasahara; L Alger; P Hirth; G Mc Mahon ; J Waltenberger; N F Voelkel; R M Tuder
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

4.  Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.

Authors:  Brett E Fenster; Luis Lasalvia; Joyce D Schroeder; Jamey Smyser; Lori J Silveira; J Kern Buckner; Kevin K Brown
Journal:  Heart Vessels       Date:  2015-05-15       Impact factor: 2.037

5.  Galectin-3 contributes to vascular fibrosis in monocrotaline-induced pulmonary arterial hypertension rat model.

Authors:  Xiaoyan Wang; Yanli Wang; Jinbo Zhang; Xue Guan; Minggang Chen; Yumei Li; Li Zhang
Journal:  J Biochem Mol Toxicol       Date:  2016-11-21       Impact factor: 3.642

6.  Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension.

Authors:  Jeremy A Mazurek; Benjamin D Horne; Wajeeha Saeed; Muhammad R Sardar; Ronald Zolty
Journal:  Heart Lung Circ       Date:  2017-02-08       Impact factor: 2.975

7.  Galectin-3 mediates the effect of PDGF on pulmonary arterial hypertension.

Authors:  Shaomei Guo; Ziming Feng
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.

Authors:  S A Harrison; S R Marri; N Chalasani; R Kohli; W Aronstein; G A Thompson; W Irish; M V Miles; S A Xanthakos; E Lawitz; M Noureddin; T D Schiano; M Siddiqui; A Sanyal; B A Neuschwander-Tetri; P G Traber
Journal:  Aliment Pharmacol Ther       Date:  2016-10-24       Impact factor: 8.171

9.  NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.

Authors:  Scott A Barman; Feng Chen; Yunchao Su; Christiana Dimitropoulou; Yusi Wang; John D Catravas; Weihong Han; Laszlo Orfi; Csaba Szantai-Kis; Gyorgy Keri; Istvan Szabadkai; Nektarios Barabutis; Olga Rafikova; Ruslan Rafikov; Stephen M Black; Danny Jonigk; Athanassios Giannis; Reto Asmis; David W Stepp; Ganesan Ramesh; David J R Fulton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-19       Impact factor: 8.311

10.  Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.

Authors:  Mingwen Hao; Miaomiao Li; Wenjun Li
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952
  10 in total
  16 in total

1.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman
Journal:  Antioxid Redox Signal       Date:  2019-03-29       Impact factor: 8.401

2.  Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.

Authors:  Scott A Barman; Zsuzsanna Bordan; Robert Batori; Stephen Haigh; David J R Fulton
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Disconnect between Fibrotic Response and Right Ventricular Dysfunction.

Authors:  Slaven Crnkovic; Bakytbek Egemnazarov; Rachel Damico; Leigh M Marsh; Bence M Nagy; Philipp Douschan; Kwame Atsina; Todd M Kolb; Stephen C Mathai; Jody E Hooper; Bahil Ghanim; Walter Klepetko; Friedrich Fruhwald; Dirk Lassner; Andrea Olschewski; Horst Olschewski; Paul M Hassoun; Grazyna Kwapiszewska
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

4.  Novel Regulators and Targets of Redox Signaling in Pulmonary Vasculature.

Authors:  Zdravka Daneva; Victor E Laubach; Swapnil K Sonkusare
Journal:  Curr Opin Physiol       Date:  2019-05-09

5.  Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis.

Authors:  Scott A Barman; Xueyi Li; Stephen Haigh; Dmitry Kondrikov; Keyvan Mahboubi; Zsuzsanna Bordan; David W Stepp; Jiliang Zhou; Yusi Wang; Daniel S Weintraub; Peter Traber; William Snider; Danny Jonigk; Jennifer Sullivan; G Ryan Crislip; Joshua T Butcher; Jennifer Thompson; Yunchao Su; Feng Chen; David J R Fulton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-06       Impact factor: 5.464

6.  Structure-based identification of galectin-1 selective modulators in dietary food polyphenols: a pharmacoinformatics approach.

Authors:  Shovonlal Bhowmick; Achintya Saha; Nora Abdullah AlFaris; Jozaa Zaidan ALTamimi; Zeid A ALOthman; Tahany Saleh Aldayel; Saikh Mohammad Wabaidur; Md Ataul Islam
Journal:  Mol Divers       Date:  2021-09-05       Impact factor: 3.364

7.  Association between a Single Nucleotide Polymorphism in the 3'-UTR of ARHGEF18 and the Risk of Nonidiopathic Pulmonary Arterial Hypertension in Chinese Population.

Authors:  Ding Li; Yan Sun; Xiaochao Kong; Changxing Luan; Youjia Yu; Feng Chen; Peng Chen
Journal:  Dis Markers       Date:  2018-10-14       Impact factor: 3.434

8.  Association between circulating Galectin-3 and arterial stiffness in older adults.

Authors:  Xiaoming Jia; Caroline Sun; Hirofumi Tanaka; Mahmoud Al Rifai; David Aguilar; Chiadi Ndumele; Elizabeth Selvin; Salim S Virani; Ron C Hoogeveen; Gerardo Heiss; Christie M Ballantyne; Vijay Nambi
Journal:  Vasa       Date:  2021-08-04       Impact factor: 1.961

Review 9.  Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.

Authors:  Anastasia Gorelova; Mariah Berman; Imad Al Ghouleh
Journal:  Antioxid Redox Signal       Date:  2021-04-20       Impact factor: 8.401

10.  Genome-wide association study identifies loci and candidate genes for non-idiopathic pulmonary hypertension in Eastern Chinese Han population.

Authors:  Caiyong Yin; Kai Li; Yanfang Yu; Huijie Huang; Youjia Yu; Zhongqun Wang; Jinchuan Yan; Yan Pu; Zheng Li; Ding Li; Peng Chen; Feng Chen
Journal:  BMC Pulm Med       Date:  2018-10-05       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.